ARTICLE | Company News
Valeant selling Dendreon to Chinese conglomerate
January 10, 2017 11:58 PM UTC
Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) is selling cancer company Dendreon Pharmaceuticals Inc. to Sanpower Group Co. Ltd. (Nanjing, China) for $819.9 million in cash. Valeant expects the deal to close this half...